Health Care & Life Sciences » Pharmaceuticals » Pfizer | Pfizer global Lipitor revenue 2003-2017

Pfizer's Lipitor revenue worldwide 2003-2017

Worldwide revenue of Pfizer's Lipitor from 2003 to 2017 (Figures expressed in millions of U.S. dollars, unless otherwise specified)
Created with Highcharts 5.0.149 2319 23110 86210 86212 18712 18712 88612 88612 67512 67512 40112 40111 43411 43410 73310 7339 5779 5773 9483 9482 3152 3152 0612 0611 8601 8601 7581 7581 9151 91520032004200520062007200820092010201120122013201420152016201702.5k5k7.5k10k12.5k15k

The data displays the global revenue of Pfizer's top product Lipitor from 2003 to 2017. Pfizer Inc. is a multinational pharmaceutical corporation. The company is headquartered in Midtown Manhattan, New York City. In 2010, Pfizer's Lipitor generated some 10.7 billion USD of revenue. Due to patent loss in end-2011, there was a large decrease in revenues. In 2017, the cholesterol-lowering drug generated about 1.9 billion USD in revenue.

2003 9231
2004 10862
2005 12187
2006 12886
2007 12675
2008 12401
2009 11434
2010 10733
2011 9577
2012 3948
2013 2315
2014 2061
2015 1860
2016 1758
2017 1915